132 related articles for article (PubMed ID: 18840469)
1. Capture of cell culture-derived influenza virus by lectins: strain independent, but host cell dependent.
Opitz L; Zimmermann A; Lehmann S; Genzel Y; Lübben H; Reichl U; Wolff MW
J Virol Methods; 2008 Dec; 154(1-2):61-8. PubMed ID: 18840469
[TBL] [Abstract][Full Text] [Related]
2. Lectin-affinity chromatography for downstream processing of MDCK cell culture derived human influenza A viruses.
Opitz L; Salaklang J; Büttner H; Reichl U; Wolff MW
Vaccine; 2007 Jan; 25(5):939-47. PubMed ID: 17011087
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of influenza virus replication in Vero and MDCK cell lines.
Youil R; Su Q; Toner TJ; Szymkowiak C; Kwan WS; Rubin B; Petrukhin L; Kiseleva I; Shaw AR; DiStefano D
J Virol Methods; 2004 Sep; 120(1):23-31. PubMed ID: 15234806
[TBL] [Abstract][Full Text] [Related]
4. Growth and immunogenicity of influenza viruses cultivated in Vero or MDCK cells and in embryonated chicken eggs.
Govorkova EA; Kodihalli S; Alymova IV; Fanget B; Webster RG
Dev Biol Stand; 1999; 98():39-51; discussion 73-4. PubMed ID: 10494958
[TBL] [Abstract][Full Text] [Related]
5. Impact of adsorbents selection on capture efficiency of cell culture derived human influenza viruses.
Opitz L; Lehmann S; Zimmermann A; Reichl U; Wolff MW
J Biotechnol; 2007 Sep; 131(3):309-17. PubMed ID: 17765993
[TBL] [Abstract][Full Text] [Related]
6. High titer growth of human and avian influenza viruses in an immortalized chick embryo cell line without the need for exogenous proteases.
Smith KA; Colvin CJ; Weber PS; Spatz SJ; Coussens PM
Vaccine; 2008 Jul; 26(29-30):3778-82. PubMed ID: 18524432
[TBL] [Abstract][Full Text] [Related]
7. Sulfated membrane adsorbers for economic pseudo-affinity capture of influenza virus particles.
Opitz L; Lehmann S; Reichl U; Wolff MW
Biotechnol Bioeng; 2009 Aug; 103(6):1144-54. PubMed ID: 19449393
[TBL] [Abstract][Full Text] [Related]
8. Glycan analysis in cell culture-based influenza vaccine production: influence of host cell line and virus strain on the glycosylation pattern of viral hemagglutinin.
Schwarzer J; Rapp E; Hennig R; Genzel Y; Jordan I; Sandig V; Reichl U
Vaccine; 2009 Jul; 27(32):4325-36. PubMed ID: 19410619
[TBL] [Abstract][Full Text] [Related]
9. Use of MDCK cells for production of live attenuated influenza vaccine.
Liu J; Shi X; Schwartz R; Kemble G
Vaccine; 2009 Oct; 27(46):6460-3. PubMed ID: 19559113
[TBL] [Abstract][Full Text] [Related]
10. Production of influenza virus in serum-free mammalian cell cultures.
Merten OW; Manuguerra JC; Hannoun C; van der Werf S
Dev Biol Stand; 1999; 98():23-37; discussion 73-4. PubMed ID: 10494957
[TBL] [Abstract][Full Text] [Related]
11. Suitability of MDCK cells grown in a serum-free medium for influenza virus production.
Kessler N; Thomas-Roche G; Gérentes L; Aymard M
Dev Biol Stand; 1999; 98():13-21; discussion 73-4. PubMed ID: 10494956
[TBL] [Abstract][Full Text] [Related]
12. Influvac: a safe Madin Darby Canine Kidney (MDCK) cell culture-based influenza vaccine.
Brands R; Visser J; Medema J; Palache AM; van Scharrenburg GJ
Dev Biol Stand; 1999; 98():93-100; discussion 111. PubMed ID: 10494962
[TBL] [Abstract][Full Text] [Related]
13. A novel mammalian cell (Vero) derived influenza virus vaccine: development, characterization and industrial scale production.
Kistner O; Barrett PN; Mundt W; Reiter M; Schober-Bendixen S; Eder G; Dorner F
Wien Klin Wochenschr; 1999 Mar; 111(5):207-14. PubMed ID: 10226351
[TBL] [Abstract][Full Text] [Related]
14. Adaptation of a Madin-Darby canine kidney cell line to suspension growth in serum-free media and comparison of its ability to produce avian influenza virus to Vero and BHK21 cell lines.
van Wielink R; Kant-Eenbergen HC; Harmsen MM; Martens DE; Wijffels RH; Coco-Martin JM
J Virol Methods; 2011 Jan; 171(1):53-60. PubMed ID: 20933017
[TBL] [Abstract][Full Text] [Related]
15. Harvesting and concentration of human influenza A virus produced in serum-free mammalian cell culture for the production of vaccines.
Kalbfuss B; Genzel Y; Wolff M; Zimmermann A; Morenweiser R; Reichl U
Biotechnol Bioeng; 2007 May; 97(1):73-85. PubMed ID: 16921531
[TBL] [Abstract][Full Text] [Related]
16. [Development of a novel influenza vaccine derived from a continuous cell line].
Kistner O; Barrett N; Mundt W; Reiter M; Schober-Bendixen S; Eder G; Dorner F
ALTEX; 2001; 18(1):50-4. PubMed ID: 11248852
[TBL] [Abstract][Full Text] [Related]
17. Purification of cell culture-derived influenza virus A/Puerto Rico/8/34 by membrane-based immobilized metal affinity chromatography.
Opitz L; Hohlweg J; Reichl U; Wolff MW
J Virol Methods; 2009 Nov; 161(2):312-6. PubMed ID: 19591872
[TBL] [Abstract][Full Text] [Related]
18. Quantitative analysis of cellular proteome alterations in human influenza A virus-infected mammalian cell lines.
Vester D; Rapp E; Gade D; Genzel Y; Reichl U
Proteomics; 2009 Jun; 9(12):3316-27. PubMed ID: 19504497
[TBL] [Abstract][Full Text] [Related]
19. MDCK cells that express proteases TMPRSS2 and HAT provide a cell system to propagate influenza viruses in the absence of trypsin and to study cleavage of HA and its inhibition.
Böttcher E; Freuer C; Steinmetzer T; Klenk HD; Garten W
Vaccine; 2009 Oct; 27(45):6324-9. PubMed ID: 19840668
[TBL] [Abstract][Full Text] [Related]
20. Development of a Vero cell-derived influenza whole virus vaccine.
Kistner O; Barrett PN; Mundt W; Reiter M; Schober-Bendixen S; Eder G; Dorner F
Dev Biol Stand; 1999; 98():101-10; discussion 111. PubMed ID: 10494963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
